Spryte Medical is pioneering the field of neurovascular imaging with its proprietary neuro Optical Coherence Tomography (n OCT) technology, which represents a significant advancement in intravascular imaging. This innovative platform allows for high-resolution imaging of cerebral arteries from within, providing insights that were previously unattainable with traditional non-invasive imaging methods. The n OCT system utilizes backscattered light to generate cross-sectional images of biological tissues at a micro-meter resolution, enabling neurointerventionalists to visualize anatomical structures and disease processes in detail. This capability is particularly crucial for understanding conditions such as brain aneurysms, ischemic strokes, and atherosclerotic intracranial disease, thereby enhancing diagnostic accuracy and treatment planning.

The n OCT imaging system is designed to navigate the complex and tortuous anatomy of the neurovascular system, integrating seamlessly into existing clinical workflows. It features a micro-optical fiber probe that functions like a wire, allowing for direct imaging of the vessel walls and surrounding structures. With its AI-powered console, the system not only improves the resolution of imaging—offering over ten times the detail of current technologies—but also aids in the development of new therapies and procedural techniques. By providing unprecedented visibility into cerebrovascular pathology, Spryte Medical's n OCT technology is set to revolutionize patient care in the neurovascular field, ultimately leading to better outcomes for patients suffering from stroke and other related conditions.

United States

Advancing cerebrovascular care through groundbreaking neuro intravascular imaging and AI technologies.

Spryte Medical

Company Details